X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs TTK HEALTHCARE - Comparison Results

WOCKHARDT    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT TTK HEALTHCARE WOCKHARDT/
TTK HEALTHCARE
 
P/E (TTM) x -19.4 17.9 - View Chart
P/BV x 1.4 1.9 72.4% View Chart
Dividend Yield % 0.0 0.9 0.3%  

Financials

 WOCKHARDT   TTK HEALTHCARE
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
TTK HEALTHCARE
Mar-18
WOCKHARDT/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,0121,458 69.4%   
Low Rs532795 66.8%   
Sales per share (Unadj.) Rs355.9408.7 87.1%  
Earnings per share (Unadj.) Rs-60.312.9 -468.8%  
Cash flow per share (Unadj.) Rs-46.823.6 -197.8%  
Dividends per share (Unadj.) Rs0.015.00 0.2%  
Dividend yield (eoy) %00.4 0.3%  
Book value per share (Unadj.) Rs257.8164.9 156.4%  
Shares outstanding (eoy) m110.6314.13 782.9%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.22.8 78.7%   
Avg P/E ratio x-12.887.6 -14.6%  
P/CF ratio (eoy) x-16.547.6 -34.6%  
Price / Book Value ratio x3.06.8 43.8%  
Dividend payout %038.9 -0.0%   
Avg Mkt Cap Rs m85,37915,916 536.4%   
No. of employees `0006.32.2 278.7%   
Total wages/salary Rs m9,3711,090 859.8%   
Avg. sales/employee Rs Th6,295.02,573.8 244.6%   
Avg. wages/employee Rs Th1,498.3485.7 308.5%   
Avg. net profit/employee Rs Th-1,066.381.0 -1,316.9%   
INCOME DATA
Net Sales Rs m39,3695,776 681.7%  
Other income Rs m1,20276 1,588.2%   
Total revenues Rs m40,5715,851 693.4%   
Gross profit Rs m18426 4.3%  
Depreciation Rs m1,495152 981.2%   
Interest Rs m2,55547 5,401.5%   
Profit before tax Rs m-2,830302 -938.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257120 214.5%   
Profit after tax Rs m-6,669182 -3,670.1%  
Gross profit margin %07.4 0.6%  
Effective tax rate %-9.139.7 -22.9%   
Net profit margin %-16.93.1 -538.4%  
BALANCE SHEET DATA
Current assets Rs m33,7962,556 1,322.2%   
Current liabilities Rs m26,9171,675 1,606.8%   
Net working cap to sales %17.515.3 114.6%  
Current ratio x1.31.5 82.3%  
Inventory Days Days7933 237.3%  
Debtors Days Days8935 255.1%  
Net fixed assets Rs m39,6641,103 3,595.5%   
Share capital Rs m553141 391.5%   
"Free" reserves Rs m27,9682,188 1,278.0%   
Net worth Rs m28,5222,330 1,224.3%   
Long term debt Rs m21,7317 329,259.1%   
Total assets Rs m81,6204,073 2,004.0%  
Interest coverage x-0.17.4 -1.5%   
Debt to equity ratio x0.80 26,894.6%  
Sales to assets ratio x0.51.4 34.0%   
Return on assets %-5.05.6 -89.6%  
Return on equity %-23.47.8 -299.8%  
Return on capital %-7.714.9 -51.4%  
Exports to sales %03.0 0.0%   
Imports to sales %00.6 0.0%   
Exports (fob) Rs mNA172 0.0%   
Imports (cif) Rs mNA35 0.0%   
Fx inflow Rs m9,807172 5,701.8%   
Fx outflow Rs m1,78955 3,243.2%   
Net fx Rs m8,019117 6,862.2%   
CASH FLOW
From Operations Rs m684253 270.5%  
From Investments Rs m6,302-226 -2,793.6%  
From Financial Activity Rs m-7,695-72 10,687.1%  
Net Cashflow Rs m-664-41 1,611.7%  

Share Holding

Indian Promoters % 74.5 65.4 113.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 3.7 62.2%  
FIIs % 7.7 5.2 148.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 25.8 59.7%  
Shareholders   67,757 12,723 532.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  STERLING BIOTECH  ASTRAZENECA PHARMA  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 160 Points Higher; IT and Healthcare Stocks Witness Buying(Closing)

Indian share markets traded on a positive note most of the day and ended higher. Gains were largely seen in the IT sector and healthcare sector, while capital goods stocks witnessed selling pressure.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

This Smallcap Stock could be the next Page Industries(Profit Hunter)

Jul 2, 2019

The smallcap rebound is taking longer to play out...and that's good news as it gives you more of action time and opportunities to invest in.

The Indian Rating Agency Cleanup Has Begun and this Cheap Stock Could be the Best Bet(The 5 Minute Wrapup)

Jul 2, 2019

The last time this big rating agency was as cheap and out-of-favour as it is today, the stock had corrected by 40% in six months.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 15, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS